# Immunotherapy And Palliative Radiotherapy Combined In Patients With Advanced Malignancy

> **NCT03042156** · — · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 42 (actual)

## Conditions studied

- Palliative
- Advanced Cancer
- Immunotherapy
- Radiation Therapy

## Interventions

- **RADIATION:** Palliative Radiation Therapy

## Key facts

- **NCT ID:** NCT03042156
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-10
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-04-30
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03042156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03042156, "Immunotherapy And Palliative Radiotherapy Combined In Patients With Advanced Malignancy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03042156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*